search
Back to results

HEMOTOL: Efficacy and Safety of Hemodialysis On-line Monitoring Devices on Hemodynamic Stability in Intensive Care Unit (HEMOTOL)

Primary Purpose

Hemodialysis

Status
Completed
Phase
Phase 2
Locations
France
Study Type
Interventional
Intervention
Standard Hemodialysis
with Blood Volume Management (BVM®) only
with Blood Volume (BVM®) and Temperature (BTM®) on-line monitoring
Sponsored by
University Hospital, Caen
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hemodialysis focused on measuring Acute Kidney Injury, Critical care, Hypotension, Renal replacement therapy, Efficacy, Tolerance, Outcome

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age > 18 years
  • Acute Kidney injury requiring intermittent hemodialysis

Exclusion Criteria:

  • Age < 18 years
  • End-stage renal failure
  • Inclusion in other protocol
  • Absence of consent

Sites / Locations

  • Service de Réanimation Médicale - CHU de Caen

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

No Intervention

Active Comparator

Active Comparator

Arm Label

Standard

2

3

Arm Description

Gold standard bicarbonate hemodialysis therapy with constant ultrafiltration rate and dialysis conductivity

With Blood Volume on-line monitoring only

With Blood volume and Blood temperature on-line monitoring

Outcomes

Primary Outcome Measures

Intra-Dialytic Hypotension

Secondary Outcome Measures

Compliance to treatment; intra-dialytic complications; dialysis dose; blood temperature control; blood volume control

Full Information

First Posted
December 15, 2008
Last Updated
March 2, 2010
Sponsor
University Hospital, Caen
search

1. Study Identification

Unique Protocol Identification Number
NCT00811109
Brief Title
HEMOTOL: Efficacy and Safety of Hemodialysis On-line Monitoring Devices on Hemodynamic Stability in Intensive Care Unit
Acronym
HEMOTOL
Official Title
HEMOTOL: Effects of New Dialysis On-line Monitoring Devices on Hemodynamic Stability During Intermittent Hemodialysis in Critically Ill Patients With Acute Kidney Injury : a Prospective Randomized Study.
Study Type
Interventional

2. Study Status

Record Verification Date
March 2010
Overall Recruitment Status
Completed
Study Start Date
December 2008 (undefined)
Primary Completion Date
January 2010 (Actual)
Study Completion Date
January 2010 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
University Hospital, Caen

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this randomized controlled study is to compare the effects of different new dialysis on-line monitoring devices on hemodynamic stability during intermittent hemodialysis in critically ill patients with acute kidney injury.
Detailed Description
Acute kidney injury (AKI) is associated with high mortality and morbidity rates in critically ill patients despite advances in renal replacement therapy (RRT). Over the last few years, new devices in dialysis equipment, such as blood temperature and blood volume on-line monitors, have been developed to improve hemodynamic tolerance, and these new modalities have demonstrated their positive impact on decrease in intra-dialytic hypotension rate in chronic hemodialysis patients. In order to evaluate these new devices in critically ill patients with acute kidney injury we decided to conduct a prospective randomized controlled trial. We based calculation of the sample size on a power analysis that assumed an expected decrease in intra-dialytic hypotension rate of 40% (from a crude intra-dialytic hypotension rate of 30% to 18%) in groups B and C, compared with group A. Analysis is done by intention to treat, according to prescribed new dialysis on-line monitoring devices.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hemodialysis
Keywords
Acute Kidney Injury, Critical care, Hypotension, Renal replacement therapy, Efficacy, Tolerance, Outcome

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
600 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Standard
Arm Type
No Intervention
Arm Description
Gold standard bicarbonate hemodialysis therapy with constant ultrafiltration rate and dialysis conductivity
Arm Title
2
Arm Type
Active Comparator
Arm Description
With Blood Volume on-line monitoring only
Arm Title
3
Arm Type
Active Comparator
Arm Description
With Blood volume and Blood temperature on-line monitoring
Intervention Type
Device
Intervention Name(s)
Standard Hemodialysis
Other Intervention Name(s)
Treatment A
Intervention Description
Gold standard bicarbonate hemodialysis therapy with constant ultrafiltration rate and dialysis conductivity performed with Fresenius 4008S monitor (Fresenius Medical Care, France)
Intervention Type
Device
Intervention Name(s)
with Blood Volume Management (BVM®) only
Other Intervention Name(s)
Treatment B
Intervention Description
Hemodialysis using Blood Volume on-line monitoring only. Hemodialysis will be performed with Fresenius 4008S monitor (Fresenius Medical Care, France) equipped with BVM® device (for blood volume monitor; Fresenius Medical Care, France)
Intervention Type
Device
Intervention Name(s)
with Blood Volume (BVM®) and Temperature (BTM®) on-line monitoring
Other Intervention Name(s)
Treatment C
Intervention Description
Hemodialysis using Blood volume and Blood temperature on-line monitoring. Hemodialysis will be performed with Fresenius 4008S monitor (Fresenius Medical Care, France) equipped with BVM® and BTM® devices (for blood volume monitor and blood temperature management, respectively; Fresenius Medical Care, France)
Primary Outcome Measure Information:
Title
Intra-Dialytic Hypotension
Time Frame
60 days
Secondary Outcome Measure Information:
Title
Compliance to treatment; intra-dialytic complications; dialysis dose; blood temperature control; blood volume control
Time Frame
60 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age > 18 years Acute Kidney injury requiring intermittent hemodialysis Exclusion Criteria: Age < 18 years End-stage renal failure Inclusion in other protocol Absence of consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Damien du CHEYRON, MD, PhD
Organizational Affiliation
University Hospital, Caen
Official's Role
Principal Investigator
Facility Information:
Facility Name
Service de Réanimation Médicale - CHU de Caen
City
Caen
ZIP/Postal Code
14000
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
22535635
Citation
du Cheyron D, Terzi N, Seguin A, Valette X, Prevost F, Ramakers M, Daubin C, Charbonneau P, Parienti JJ. Use of online blood volume and blood temperature monitoring during haemodialysis in critically ill patients with acute kidney injury: a single-centre randomized controlled trial. Nephrol Dial Transplant. 2013 Feb;28(2):430-7. doi: 10.1093/ndt/gfs124. Epub 2012 Apr 25.
Results Reference
derived

Learn more about this trial

HEMOTOL: Efficacy and Safety of Hemodialysis On-line Monitoring Devices on Hemodynamic Stability in Intensive Care Unit

We'll reach out to this number within 24 hrs